- HAWLEY HB
Long COVID: Clinical Findings, Pathology, and Endothelial Molecular Mechanisms.
Am J Med. 2025;138:91-97.
PubMed Abstract available - HAYES LD, Sanal-Hayes NEM, Mclaughlin M, Berry ECJ, et al
People with Long Covid and ME/CFS Exhibit Similarly Impaired Balance and Physical Capacity: A Case-Case-Control Study.
Am J Med. 2025;138:140-147.
PubMed Abstract available - MCLAUGHLIN M, Cerexhe L, Macdonald E, Ingram J, et al
A Cross-Sectional Study of Symptom Prevalence, Frequency, Severity, and Impact of Long COVID in Scotland: Part I.
Am J Med. 2025;138:121-130.
PubMed Abstract available - HONDA H, Takamatsu A, Miwa T, Tabuchi T, et al
Prolonged Symptoms after COVID-19 in Japan: A Nationwide Survey of the Symptoms and Their Impact on Patients' Quality of Life.
Am J Med. 2025;138:98-107.
PubMed Abstract available - BAILEY J, Lavelle B, Miller J, Jimenez M, et al
Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort Study.
Am J Med. 2025;138:108-120.
PubMed Abstract available - XUEREB RA, Borg M, Vella K, Gatt A, et al
Long COVID Syndrome: A Case-Control Study.
Am J Med. 2025;138:131-139.
PubMed Abstract available - HASLAM A, Prasad V
Comparability of Control and Comparison Groups in Studies Assessing Long COVID.
Am J Med. 2025;138:148-152.
PubMed Abstract available - VASSILOPOULOS S, Mylonakis E
After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
PubMed Abstract available - MCGOVERN-GOOCH KR, Mani N, Gotchev D, Ardzinski A, et al
Biological characterization of AB-343, a novel and potent SARS-CoV-2 M(pro) inhibitor with pan-coronavirus activity.
Antiviral Res. 2024;232:106038.
PubMed Abstract available - SASAKI J, Sato A, Sasaki M, Okabe I, et al
X-206 exhibits broad-spectrum anti-beta-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates.
Antiviral Res. 2024 Nov 19:106039. doi: 10.1016/j.antiviral.2024.106039.
PubMed Abstract available - WELCH SR, Bilello JP, Carter K, Delang L, et al
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research.
Antiviral Res. 2024;232:106037.
PubMed Abstract available - NAKASHIMA M, Nobori H, Kuroda T, Shimba A, et al
Oral 3CL protease inhibitor ensitrelvir suppressed SARS-CoV-2 shedding and infection in a hamster aerosol transmission model.
Antiviral Res. 2024 Oct 28:106026. doi: 10.1016/j.antiviral.2024.106026.
PubMed Abstract available - ZALI M, Sadat Larijani M, Bavand A, Moradi L, et al
Circulatory microRNAs as potential biomarkers for different aspects of COVID-19.
Arch Virol. 2024;170:8.
PubMed Abstract available - NAVARRO-LOPEZ R, Valdez-Gomez HE, Zalapa-Hernandez M, Solis-Hernandez M, et al
An epizootic of highly pathogenic avian influenza virus H7N3 in a Mexican ecological reserve.
Arch Virol. 2024;170:6.
PubMed Abstract available - GUNASEKARA E, Hair-Bejo M, Aini I, Omar AR, et al
Molecular characterisation of novel reassortants of the G57 genotype of low-pathogenic avian influenza H9N2 virus isolated from poultry farms in Malaysia.
Arch Virol. 2024;170:3.
PubMed Abstract available - HOSOKAWA K, Ohmori H
Digital reverse transcription PCR using a simple poly(dimethylsiloxane) microwell array chip for detection of SARS-CoV-2.
Biochem Biophys Res Commun. 2024;741:151070.
PubMed Abstract available - LIN F, Liang JL, Guan ZX, Wu M, et al
Hospitalized children with influenza A before, during and after COVID-19 pandemic: a retrospective cohort study.
BMC Pediatr. 2024;24:828.
PubMed Abstract available - FLYNN SG, Park RS, Jena AB, Staffa SJ, et al
Coaching inexperienced clinicians before a high stakes medical procedure: randomized clinical trial.
BMJ. 2024;387:e080924.
PubMed Abstract available - BONCYK C, Rolfsen ML, Richards D, Stollings JL, et al
Management of pain and sedation in the intensive care unit.
BMJ. 2024;387:e079789.
PubMed Abstract available - ROSEN LE, Tortorici MA, De Marco A, Pinto D, et al
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
Cell. 2024;187:7196-7213.
PubMed Abstract available - ZHENG C, Yu FY, Chan PS, Sun F, et al
Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study.
Epidemiol Infect. 2024;152:e166.
PubMed Abstract available - WANG S, Yan J, Song M, Xue Z, et al
Development of a nomogram for high antibody titre of COVID-19 convalescent plasma.
Epidemiol Infect. 2024;152:e167.
PubMed Abstract available - IOANNIDIS JPA
Differential risk of healthcare workers versus the general population during outbreak, war and pandemic crises.
Eur J Epidemiol. 2024;39:1211-1219.
PubMed Abstract available - NARAYANAN MK, Dodgeon B, Katsoulis M, Ploubidis GB, et al
How to mitigate selection bias in COVID-19 surveys: evidence from five national cohorts.
Eur J Epidemiol. 2024;39:1221-1227.
PubMed Abstract available - GRENINGER AL, Larcena A, Patel A, Webster B, et al
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs.
J Clin Microbiol. 2024;62:e0121924.
PubMed Abstract available - KRISHNA B, Metaxaki M, Perera M, Wills M, et al
Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection.
J Gen Virol. 2024;105.
PubMed Abstract available - ALNAJJAR S, Larios-Mora A, Van-Geelen A, Gallup J, et al
Therapeutic efficacy of JNJ-49214698, an RSV fusion inhibitor, in RSV-infected neonatal lambs.
J Gen Virol. 2024;105:002056.
PubMed Abstract available - JIA T, Wang F, Chen Y, Liao G, et al
Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination.
J Infect. 2024 Nov 26:106362. doi: 10.1016/j.jinf.2024.106362.
PubMed Abstract available - CHOW KN, Tsang YW, Chan YH, Telaga SA, et al
The effect of pre-COVID and post-COVID vaccination on long COVID: a systematic review and meta-analysis.
J Infect. 2024 Nov 21:106358. doi: 10.1016/j.jinf.2024.106358.
PubMed Abstract available - REN Z, Yang M, Su G, Qian G, et al
Real-world effectiveness and safety of Azvudine in hospitalized patients with SARS-CoV-2 infection: a multicenter, retrospective cohort study.
J Infect. 2024 Nov 17:106355. doi: 10.1016/j.jinf.2024.106355.
PubMed Abstract available - MCLEOD C, Dymock M, Flanagan KL, Plebanski M, et al
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.
J Infect. 2024 Nov 14:106346. doi: 10.1016/j.jinf.2024.106346.
PubMed Abstract available - HAN B, Du C, Deng M, Tang R, et al
Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in China.
J Infect. 2024 Nov 7:106339. doi: 10.1016/j.jinf.2024.106339.
PubMed Abstract available - DULFER EA, Fohse K, Taks EJM, Moorlag SJCFM, et al
The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseases.
J Infect. 2024;89:106344.
PubMed Abstract available - CITRON MP, Zang X, Leithead A, Meng S, et al
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals models.
J Infect. 2024;89:106325.
PubMed Abstract available - KUMAR NP, Balaji S, Devi PG, Ramraj B, et al
Inflammatory Cytokine Responses in Pediatric tuberculosis with or without SARS-CoV-2 seropositivity.
J Infect. 2024 Oct 17:106314. doi: 10.1016/j.jinf.2024.106314.
PubMed Abstract available - WEI X, Wang L, Li M, Qi J, et al
Novel imported clades accelerated the RSV surge in Beijing, China, 2023-2024.
J Infect. 2024 Oct 17:106321. doi: 10.1016/j.jinf.2024.106321.
PubMed Abstract available - MEIRMAN TD, Shapira B, Balicer RD, Rokach L, et al
Trends of Common Laboratory Biomarkers after SARS-CoV-2 Infection.
J Infect. 2024 Oct 16:106318. doi: 10.1016/j.jinf.2024.106318.
PubMed Abstract available - CHEN X, Meng X, Wu Q, Lim WW, et al
Assessment of Neutralizing Antibody Response as a Correlate of Protection against Symptomatic SARS-CoV-2 Infections after Administration of two doses of the CoronaVac inactivated COVID-19 Vaccine: A Phase III Randomized Controlled Trial.
J Infect. 2024 Oct 16:106315. doi: 10.1016/j.jinf.2024.106315.
PubMed Abstract available - MADSEN AMR, Gehrt L, Schaltz-Buchholzer F, Moller S, et al
Evaluating the effect of BCG vaccination for non-specific protection from infection in senior citizens during the COVID-19 pandemic: a randomised clinical trial.
J Infect. 2024 Oct 16:106319. doi: 10.1016/j.jinf.2024.106319.
PubMed Abstract available - MARCHESE AM, Fries L, Beyhaghi H, Vadivale M, et al
Mechanisms and Implications of IgG4 Responses to SARS-CoV-2 and Other Repeatedly Administered Vaccines.
J Infect. 2024 Oct 15:106317. doi: 10.1016/j.jinf.2024.106317.
PubMed Abstract available - LI Y, Zhang X, Yi J, Chen Y, et al
Synergistic evolution: the dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world.
J Infect. 2024 Oct 9:106310. doi: 10.1016/j.jinf.2024.106310.
PubMed Abstract available - ALOISIO GM, Nagaraj D, Murray AM, Schultz EM, et al
Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection.
J Infect. 2024;89:106305.
PubMed Abstract available - AMARILLA-IRUSTA A, Zenarruzabeitia O, Sevilla A, Sanda V, et al
CD151 identifies a NK cell subset that is enriched in COVID-19 patients and correlates with disease severity.
J Infect. 2024 Oct 5:106304. doi: 10.1016/j.jinf.2024.106304.
PubMed Abstract available - FYLES M, Overton CE, Ward T, Bennett E, et al
Modelling multiplex testing for outbreak control.
J Infect. 2024 Oct 1:106303. doi: 10.1016/j.jinf.2024.106303.
PubMed Abstract available - AKSU MD, van der Ent T, Zhang Z, Riza AL, et al
Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis.
J Infect. 2024 Sep 30:106300. doi: 10.1016/j.jinf.2024.106300.
PubMed Abstract available - DEHLIA A, Guthridge MA
The persistence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) after SARS-CoV-2 infection: A systematic review and meta-analysis.
J Infect. 2024 Sep 29:106297. doi: 10.1016/j.jinf.2024.106297.
PubMed Abstract available - BENNETT C, Hoosain Z, Koen A, Lalloo U, et al
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial.
J Infect. 2024 Sep 27:106285. doi: 10.1016/j.jinf.2024.106285.
PubMed Abstract available - MCLEOD C, Dymock, Flanagan KL, Plebanski M, et al
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.
J Infect. 2024 Sep 26:106286. doi: 10.1016/j.jinf.2024.106286.
PubMed Abstract available - HAMMERTON SM, Billings WZ, Hemme H, Ross TM, et al
Estimating standard-dose and high-dose Fluzone vaccine efficacies for influenza A based on HAI titers.
J Infect Dis. 2024 Dec 13:jiae615. doi: 10.1093.
PubMed Abstract available - TANG Y, Boribong BP, Swank ZN, Demokritou M, et al
COVID-19 mRNA vaccines induce robust levels of IgG but limited amounts of IgA within the oronasopharynx of young children.
J Infect Dis. 2024 Sep 10:jiae450. doi: 10.1093.
PubMed Abstract available - JANES H, Fisher LH, Kee JJ, Parameswaran L, et al
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
J Infect Dis. 2024 Sep 3:jiae400. doi: 10.1093.
PubMed Abstract available - ANDERSON EJ, Tippett A, Begier E, Gibson T, et al
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States.
J Infect Dis. 2024;230:1342-1351.
PubMed Abstract available - DOTY B, Ghaswalla P, Bohn RL, Stoszek SK, et al
Incidence of RSV in Adults: A Comprehensive Review of Observational Studies and Critical Gaps in Information.
J Infect Dis. 2024;230:e1182-e1201.
PubMed Abstract available - ANDRES C, Perramon-Malavez A, Creus-Costa A, Gatell A, et al
Respiratory Viral Coinfections in Pediatric Patients in the Primary Care Setting: A Multicenter Prospective Study Within the COPEDICAT Network.
J Infect Dis. 2024;230:1337-1341.
PubMed Abstract available - PATINO-GALINDO J, Garcia-Sastre A, Kuhn JH, Rabadan R, et al
Recombination across distant coronavirid species and genera is a rare event with distinct genomic features.
J Virol. 2024 Nov 19:e0110024. doi: 10.1128/jvi.01100.
PubMed Abstract available - XIONG Y, Tao K, Li T, Zhou Y, et al
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
J Virol. 2024;98:e0153624.
PubMed Abstract available - NEAL HE, Barrett CT, Edmonds K, Moncman CL, et al
Examination of respiratory syncytial virus fusion protein proteolytic processing and roles of the P27 domain.
J Virol. 2024;98:e0163924.
PubMed Abstract available - CHEN D, Zhang W, Xiao B, Xu B, et al
Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285.
PubMed Abstract available - TAKAHASHI T, Amarbayasgalan S, Ueno S, Sugiura Y, et al
Lethal model for respiratory syncytial virus infection using C57BL/6 mice.
J Virol. 2024;98:e0177224.
PubMed Abstract available - STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223.
PubMed Abstract available - PARRY RH, Lytras S, Petrone ME, Wille M, et al
No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468.
PubMed Abstract available - ASHLEY CL, Bloul M, Alca S, Smith L, et al
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
J Virol Methods. 2025;332:115073.
PubMed Abstract available - DA SILVA JG, Arruk VG, Veiga GRLD, Sousa LVA, et al
Quantitative and qualitative analysis of seroconversion after one year of vaccination with inactivated SARS-CoV-2 vaccine (CoronaVac(R)) in healthcare workers: Cross-sectional analytical study.
J Virol Methods. 2025;332:115067.
PubMed Abstract available - FIBRIANI A, Naisanu K, Yamahoki N, Kinanti DR, et al
Development of polyclonal chicken egg yolk immunoglobulin Y (IgY) antibodies targeting SARS-CoV-2 multi-epitope antigen.
J Virol Methods. 2025;331:115062.
PubMed Abstract available - YAMAZAKI Y, Tanaka R, Castillo G, Macalanda AMC, et al
Development of a concentration method for simple and sensitive detection of SARS-CoV-2 in saliva using a magnetic nanoparticle kit.
J Virol Methods. 2025;331:115059.
PubMed Abstract available - MDUNYELWA A, Seema C, Mabaso A, Mlambo K, et al
Evaluation of the Seegene Allplex RV master assay for one-step simultaneous detection of eight respiratory viruses in nasopharyngeal specimens.
J Virol Methods. 2025;331:115042.
PubMed Abstract available - TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
Differences in Drug Shortages in the US and Canada.
JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
PubMed Abstract available - DZAU VJ, Laitner MH, Shambaugh EL
Strategic imperatives for health in the USA: a roadmap for the incoming presidential administration.
Lancet. 2024;404:2371-2379.
PubMed Abstract available
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024;404:2314-2340.
PubMed Abstract available- MARIANI A, Tiryaki S, Harms M, Orlov V, et al
What we learned from the COVID-19 first wave: a survey from Young Pediatric Urology Committee (YPUC) from ESPU.
Minerva Pediatr (Torino). 2024;76:735-742.
PubMed Abstract available - ABDIRIZAK F, Winn AK, Parikh R, Scobie HM, et al
Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting - United States, 2017-2023.
MMWR Morb Mortal Wkly Rep. 2024;73:1136-1141.
PubMed Abstract available - KUCHARSKI AJ
Controlling minor outbreaks is necessary to prepare for major pandemics.
PLoS Biol. 2024;22:e3002945.
PubMed Abstract available - SOEORG H, Abroi A, Pall T, Dotsenko L, et al
Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022.
PLoS One. 2024;19:e0316213.
PubMed Abstract available - CHAE SW, Hara N, Shiroiya HR, Chen J, et al
Being vulnerable with viewers: Exploring how medical YouTubers communicated about COVID-19 with the public.
PLoS One. 2024;19:e0313857.
PubMed Abstract available - GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination.
PLoS One. 2024;19:e0315499.
PubMed Abstract available - ZAMIR MT, Ullah F, Tariq R, Bangyal WH, et al
Machine and deep learning algorithms for sentiment analysis during COVID-19: A vision to create fake news resistant society.
PLoS One. 2024;19:e0315407.
PubMed Abstract available - WEBSTER M, Manoukian S, McKendrick JH, Biosca O, et al
Exploring the gender gap in young adult mental health during COVID-19: Evidence from the UK.
PLoS One. 2024;19:e0305680.
PubMed Abstract available - SULTANA KAKOLY N, Hasan SMK, Hoque MM, Ratul RH, et al
Sociodemographic factors, clinical characteristics, outcomes and short-term follow-up in COVID-19 patients with new onset hyperglycemia and pre-existing diabetes on admission in a tertiary-care hospital in Bangladesh.
PLoS One. 2024;19:e0311508.
PubMed Abstract available - SAMBEL AYKUTLU M, Aykutlu HC, Ozveren M, Garip R, et al
Digital media use and its effects on digital eye strain and sleep quality in adolescents: A new emerging epidemic?
PLoS One. 2024;19:e0314390.
PubMed Abstract available - SU H, Yang PL, Eaton TL, Valley TS, et al
Cognition, function, and mood post-COVID-19: Comparative analysis using the health and retirement study.
PLoS One. 2024;19:e0315425.
PubMed Abstract available - LE GOFF D, Perraud G, Leon M, Aujoulat P, et al
Innovative population-based strategies for primary prevention of cardiovascular disease: A 2-year randomised control trial evaluating behavioral change led by community champions versus brief advice.
PLoS One. 2024;19:e0314748.
PubMed Abstract available - CHANG H, Li S, Ke X, Zhou Z, et al
Differences in emergency hospitalization trauma patients during and after the COVID-19 pandemic.
PLoS One. 2024;19:e0315416.
PubMed Abstract available - BOUTHILLIER ME, Farmer Y, Calderon Ramirez C, Downar J, et al
Public perspectives on COVID-19 triage protocols for access to critical care in extreme pandemic context.
PLoS One. 2024;19:e0314460.
PubMed Abstract available - SARKAR J
To test or not to test? A new behavioral epidemiology framework for COVID-19.
PLoS One. 2024;19:e0309423.
PubMed Abstract available - MOBARAK H, Haddad C, Salameh P, Towair E, et al
The relationship between self-determination and burnout: Mental health outcomes in medical residents.
PLoS One. 2024;19:e0308897.
PubMed Abstract available - SANTARPIA JL, Lau J, Shom D, Ratnesar-Shumate SA, et al
Association between in situ ventilation and human-generated aerosol exposure in meatpacking plants during the COVID-19 pandemic.
PLoS One. 2024;19:e0314856.
PubMed Abstract available - BEIG M, Parvizi E, Navidifar T, Bostanghadiri N, et al
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.
PLoS One. 2024;19:e0311124.
PubMed Abstract available - DJAILEB A, Parker MF, Lavallee E, Stuible M, et al
Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets.
PLoS One. 2024;19:e0314499.
PubMed Abstract available - ZHENG J, Li B, Jia L, Zhang J, et al
Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.
PLoS One. 2024;19:e0311069.
PubMed Abstract available - KITAMURA K, Arita M
Evaluation of VP4-VP2 sequencing for molecular typing of human enteroviruses.
PLoS One. 2024;19:e0311806.
PubMed Abstract available - LIU C, Ma H, Wang X, Cui J, et al
A comparative study of dynamic risk spillovers among financial sectors in China before and after the epidemic.
PLoS One. 2024;19:e0314071.
PubMed Abstract available - UDOH E, Okonkwo O, Omoregie G, Ura-Akubo V, et al
Service quality in decentralized community-based Covid-19 antigen rapid diagnostic testing programmes in the Federal Capital Territory, Nigeria.
PLoS One. 2024;19:e0310294.
PubMed Abstract available - PARK S, Bangirana P, Mupere E, Baluku RI, et al
Association of COVID-19-related perceptions and experiences with depression and anxiety in Ugandan caregivers of young children with malaria and iron deficiency: A cross-sectional study.
PLoS One. 2024;19:e0314409.
PubMed Abstract available - KOSTADINOV M, Zdravevski E, Lameski P, Coelho PJ, et al
Forecasting air pollution with deep learning with a focus on impact of urban traffic on PM10 and noise pollution.
PLoS One. 2024;19:e0313356.
PubMed Abstract available - MAGHSOODI E, Hasanpour E, Soleimani F, Aghal M, et al
Evaluation of anxiety level and the factors Affecting Anxiety in health care workers in Shahid Dr. Gholipour Hospital, Bukan, Iran during COVID-19 pandemic.
PLoS One. 2024;19:e0264916.
PubMed Abstract available - KE Y, Yang M, Xie Y
An empirical research based on spatial-temporal evolution of high-quality tourism development in Fujian Province of China.
PLoS One. 2024;19:e0315221.
PubMed Abstract available - SAENGER TR, Kapstein EB, Sircar R
Estimating the collapse of Afghanistan's economy using nightlights data.
PLoS One. 2024;19:e0315337.
PubMed Abstract available - SSEMATIMBA A, Malladi S, Bonney PJ, St Charles KM, et al
Estimating the time of Highly Pathogenic Avian Influenza virus introduction into United States poultry flocks during the 2022/24 epizootic.
PLoS One. 2024;19:e0310733.
PubMed Abstract available - BOCCOLINI PMM, Boclin KLS, de Sousa IMC, Boccolini CS, et al
Use of integrative and complementary practices in Brazil during the COVID-19 pandemic.
PLoS One. 2024;19:e0311832.
PubMed Abstract available - GABARRELL-PASCUET A, Coll-Planas L, Alias SB, Pascual RM, et al
Reducing loneliness and depressive symptoms in older adults during the COVID-19 pandemic: A pre-post evaluation of a psychosocial online intervention.
PLoS One. 2024;19:e0311883.
PubMed Abstract available - D'SOUZA GC, Yingst JM, Krebs NM, Bordner C, et al
Using the diffusion of innovations theory to understand factors associated with COVID-19 vaccination among tobacco users.
PLoS One. 2024;19:e0309780.
PubMed Abstract available - WAFUBWA RN, Soler-Hampejsek E, Muluve E, Osuka D, et al
Adolescent school retention post COVID-19 school closures in Kenya: A mixed-methods study.
PLoS One. 2024;19:e0315497.
PubMed Abstract available - AN Q, Wu J, Chen WH
Using the SEIQR model with epidemic amplifier effect to predict the final outbreak size of the COVID-19 in Dalian, Liaoning province, China.
PLoS One. 2024;19:e0307239.
PubMed Abstract available - SARAGOSA M, Goraya F, Nowrouzi-Kia B, Gohar B, et al
A qualitative study examining stressors among Respiratory Therapists in Ontario amidst the COVID-19 pandemic.
PLoS One. 2024;19:e0312504.
PubMed Abstract available - POZO JI, Cabellos B, Perez Echeverria MDP
Has the educational use of digital technologies changed after the pandemic? A longitudinal study.
PLoS One. 2024;19:e0311695.
PubMed Abstract available - ROBINSON JL, Kellner JD, Crotts J, Travassos G, et al
Accuracy of the diagnosis of pneumonia in Canadian pediatric emergency departments: A prospective cohort study.
PLoS One. 2024;19:e0311201.
PubMed Abstract available - ARPPO A, Barker H, Parkkila S
Bioinformatic characterization of ENPEP, the gene encoding a potential cofactor for SARS-CoV-2 infection.
PLoS One. 2024;19:e0307731.
PubMed Abstract available - KE T, Livingston M, Zhang Y, Pavlyshyn D, et al
A longitudinal study of alcohol consumption among adults in Victoria, Australia during the COVID-19 pandemic.
PLoS One. 2024;19:e0313599.
PubMed Abstract available - MORITA S, Tokumasu K, Otsuka Y, Honda H, et al
Phase-dependent trends in the prevalence of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) related to long COVID: A criteria-based retrospective study in Japan.
PLoS One. 2024;19:e0315385.
PubMed Abstract available - DAGNAW TE, Delie AM, Kassie TD, Berihun S, et al
Knowledge, attitude, and practice towards COVID-19 and associated factors among students in Ethiopia: Systematic review and meta-analysis.
PLoS One. 2024;19:e0314451.
PubMed Abstract available - RAHMAN MM, Pradhan MR, Ghosh MK, Rahman MM, et al
The impact of COVID-19 pandemic on fertility behaviour in Indian states: Evidence from the National Family Health Survey (2019/21).
PLoS One. 2024;19:e0314800.
PubMed Abstract available - VICKERS P, Adamo L, Alfano M, Clark C, et al
Development of a novel methodology for ascertaining scientific opinion and extent of agreement.
PLoS One. 2024;19:e0313541.
PubMed Abstract available - SUGIURA Y, Shimizu K, Takahashi T, Ueno S, et al
Amino acid T25 in the substrate-binding domain of SARS-CoV-2 nsp5 is involved in viral replication in the mouse lung.
PLoS One. 2024;19:e0312800.
PubMed Abstract available
Correction for Rockey et al., Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.
Proc Natl Acad Sci U S A. 2024;121:e2424158121.
PubMed- WILLIAMS JTB, Ritger C, Holliman BD, Huebschmann AG, et al
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system.
Vaccine. 2024;45:126572.
PubMed Abstract available - XIA M, Huang P, Vago FS, Jiang W, et al
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges.
Vaccine. 2024 Dec 7:126585. doi: 10.1016/j.vaccine.2024.126585.
PubMed Abstract available - KAPLAN BS, Souza CK, Kimble JB, Brand MW, et al
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine.
Vaccine. 2024 Dec 6:126574. doi: 10.1016/j.vaccine.2024.126574.
PubMed Abstract available - MARCHESE AM, Beyhaghi H, Rousculp MD, Huang V, et al
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST).
Vaccine. 2025;44:126569.
PubMed Abstract available - FILIMONOVIC J, Stosic M, Gazibara T, Dotlic J, et al
The trend in national childhood immunization program coverage throughout Serbian communities in Kosovo and Metohija from 2003 to 2022: pre-COVID-19 period vs. COVID-19 pandemic.
Vaccine. 2025;44:126576.
PubMed Abstract available - PICHE-RENAUD PP, Drover SSM, Austin PC, Morris SK, et al
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study.
Vaccine. 2024 Nov 30:126539. doi: 10.1016/j.vaccine.2024.126539.
PubMed Abstract available - HARTEVELD LM, van Leeuwen LM, Euser SM, Smit LJ, et al
Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands.
Vaccine. 2025;44:126541.
PubMed Abstract available - COSMA C, Radi A, Cattano R, Zanobini P, et al
Exploring Chatbot contributions to enhancing vaccine literacy and uptake: A scoping review of the literature.
Vaccine. 2024;44:126559.
PubMed Abstract available - FLORES D, Luna EM
The effectiveness of vaccines against COVID-19 in Mexico: A time series approach.
Vaccine. 2024;44:126565.
PubMed Abstract available - THIEM VD, Anh DD, Ha VH, Van Thom N, et al
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.
Vaccine. 2024;44:126542.
PubMed Abstract available - WANG Q, Yang L, Li L, Xiu S, et al
Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study.
Vaccine. 2024;44:126570.
PubMed Abstract available - GEMANDER N, Kemlin D, Depickere S, Kelkar NS, et al
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.
Vaccine. 2024;44:126544.
PubMed Abstract available - BLUKACZ A, Obach A, Vasquez P, Campana C, et al
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis.
Vaccine. 2024;44:126546.
PubMed Abstract available - AMODIO D, Angelidou A, Cotugno N, Sherman AC, et al
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Vaccine. 2024;43.
PubMed Abstract available - DE LIMA EDS, Antunes MOB, de Souza JS, Jones MH, et al
Effectiveness of BNT162b2 and CoronaVac against COVID-19-related severe outcomes among children and adolescents: A Brazilian nationwide cohort study.
Vaccine. 2025;44:126550.
PubMed Abstract available - DEAN NE, Halloran ME, Zarnitsyna VI
Poor vaccine responders mask the true trend in vaccine effectiveness against progression to severe disease.
Vaccine. 2024;43.
PubMed Abstract available - LEE M, Qin C, Lee Y, Deng J, et al
COVID-19 vaccine acceptance and 5C psychological antecedents amid the omicron surge in South Korea and China.
Vaccine. 2024;43.
PubMed Abstract available - DE OLIVEIRA LA, de Morais IRB, Marchioro SB, de Almeida GB, et al
Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents.
Vaccine. 2024;43.
PubMed Abstract available - MEELDIJK A, Vandeberg L, Akkermans R, Hautvast J, et al
How text message reminders increase COVID-19 booster vaccine uptake: Two randomized controlled trials.
Vaccine. 2024;43.
PubMed Abstract available - LOCKMAN A, Callaghan T, Blackburn CC, Colwell B, et al
Vaccine spillover effects in Africa: A cross-national study of vaccine spillover and confidence in Kenya, Nigeria, and South Africa.
Vaccine. 2024;43.
PubMed Abstract available - JASTORFF A, Gymnopoulou E, Salas J, Merrall E, et al
Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial.
Vaccine. 2024;43.
PubMed Abstract available - REGAN AK, Couture MC, Callaghan T, Agnew B, et al
Modification and validation of a vaccine hesitancy scale for adolescent COVID-19 vaccination.
Vaccine. 2024;43.
PubMed Abstract available - LOPEZ-MACIAS C, Torres M, Armenta-Copca B, Wacher NH, et al
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 "Patria" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico.
Vaccine. 2024;43.
PubMed Abstract available - GWAK E, Choe SA, Bolormaa E, Choe YJ, et al
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea.
Vaccine. 2024;43.
PubMed Abstract available - WILLIAMS E, Echeverri Tribin F, Carreno JM, Krammer F, et al
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2.
Vaccine. 2024;43.
PubMed Abstract available - MATTES F, Dratva J, Schmelzer S, Wagner A, et al
The association between service experience in vaccination centers and expectation confirmation as a driver of future vaccination intentions: Results from a survey among users of a Swiss mass COVID-19 vaccination center.
Vaccine. 2024;43.
PubMed Abstract available - AGUIRRE-CAMACHO A, Hidalgo B, Rash JA
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study.
Vaccine. 2024;43.
PubMed Abstract available - HAEBERER M, Lopez-Ibanez de Aldecoa A, Seabroke S, Ramirez Agudelo JL, et al
Economic burden of children hospitalized with respiratory syncytial virus infection in Spain, 2016-2019.
Vaccine. 2025;43.
PubMed Abstract available - DENG Y, Hayes KN, Zhao Y, Chachlani P, et al
Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults.
Vaccine. 2024;43.
PubMed Abstract available - STEFFENS MS, Bolsewicz KT, King C, Bullivant B, et al
Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic.
Vaccine. 2024;43.
PubMed Abstract available - LE MARCHAND C, Singson JRC, Clark A, Shah D, et al
Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California.
Vaccine. 2024;43.
PubMed Abstract available - DELARUELLE K, Lermytte E, Bockstal M, Vuolanto P, et al
Unraveling COVID-19 vaccine hesitancy in Europeans 50 and older through a lens of preventive practices.
Vaccine. 2024;43.
PubMed Abstract available - KIM SA, Maeda M, Murata F, Fukuda H, et al
Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study.
Vaccine. 2024;43.
PubMed Abstract available - MOHD HISHAM AA, Mat Yassim AS, Suppian R, Azlan M, et al
Comparable and sustained levels of S1-RBD-IgG and S1-RBD-IgA in BNT162b2 homologous and CoronaVac-BNT162b2 heterologous booster vaccination: A 22-month prospective study in Malaysia.
Vaccine. 2024;42:126471.
PubMed Abstract available - CHARLAND K, Quach C, Papenburg J, Pierce L, et al
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada.
Vaccine. 2024;43.
PubMed Abstract available - HOFSTETTER AM, Klein EJ, Strelitz B, Selvarangan R, et al
On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network.
Vaccine. 2024;42:126455.
PubMed Abstract available - WHITE TM, Lazarus JV, Rabin KH, Ratzan SC, et al
Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023.
Vaccine. 2024;42:126475.
PubMed Abstract available - EBERHARDT J, Al-Qerem W, Ling J
Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: The role of protection motivation theory, conspiracy beliefs, social media use and religiosity.
Vaccine. 2024;42:126474.
PubMed Abstract available - MCGREGOR R, Paterson A, Lavender B, Hooker C, et al
The SARS-CoV-2 neutralising antibody profile of New Zealand adults in 2023: Impact of vaccination and infection.
Vaccine. 2024;42:126482.
PubMed Abstract available - LENTAKIS E, Seale H, Lazarus R, Mounier-Jack S, et al
Exploring the delivery of adult vaccination outside of primary care settings: A mixed methods scoping review.
Vaccine. 2024;42:126458.
PubMed Abstract available - HO TC, Chuang SC, Hung KC, Chang CC, et al
Exploring risk factors for Raynaud's phenomenon post COVID-19 vaccination.
Vaccine. 2024;42:126470.
PubMed Abstract available - LENTAKIS E, Seale H, Lazarus R, Mounier-Jack S, et al
Exploring the attitudes and practices of adult service users and providers towards vaccination in non-primary care settings: A mixed methods scoping review.
Vaccine. 2024;42:126472.
PubMed Abstract available - JORDAN E, Jenkins V, Silbernagl G, Chavez MPV, et al
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study.
Vaccine. 2024;42:126427.
PubMed Abstract available - NG AJJ, Teo DCH, Dorajoo SR, Yap AJY, et al
Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore.
Vaccine. 2024;42:126462.
PubMed Abstract available - DARKO DM, Seaneke SK, Karikari-Boateng E, Nkansah E, et al
Safety of mRNA COVID-19 vaccines among persons 15- years and above in Ghana: A cohort event monitoring study.
Vaccine. 2024;42:126460.
PubMed Abstract available - AB RAHMAN N, King TL, Peariasamy KM, Sivasampu S, et al
Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study.
Vaccine. 2024;42:126465.
PubMed Abstract available - SHARFF KA, Tandy TK, Lewis PF, Johnson ES, et al
Incidence of ischemic stroke after COVID-19 bivalent booster vaccination in an integrated health system.
Vaccine. 2024;42:126440.
PubMed Abstract available - WICKLINE MM, Carpenter PA, Harris JR, Iribarren SJ, et al
Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysis.
Vaccine. 2024;42:126374.
PubMed Abstract available - HARRACHE A, Saker K, Mokdad B, Generenaz L, et al
Anti-RBD IgG dynamics following infection or vaccination.
Vaccine. 2024;42:126464.
PubMed Abstract available - MA SH, Chen TL, Ou WF, Chao WC, et al
The risk of postherpetic neuralgia in COVID-19 vaccination-associated herpes zoster: A retrospective cohort study using TriNetX.
Vaccine. 2024;42:126451.
PubMed Abstract available - EVIATAR T, Ziv A, Oved A, Miller-Barmak A, et al
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study.
Vaccine. 2024;42:126426.
PubMed Abstract available - NAZARENO AL, Newall AT, Muscatello DJ, Hogan AB, et al
Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia.
Vaccine. 2024;42:126418.
PubMed Abstract available - SANO K, Kurosawa T, Horikawa K, Kimura Y, et al
Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan.
Vaccine. 2024;42:126452.
PubMed Abstract available - NUZHATH T, Colwell B, Callaghan T, Hotez P, et al
Pediatric COVID-19 vaccine hesitancy among pregnant and post-partum women: A mixed-method study.
Vaccine. 2024;42:126420.
PubMed Abstract available - EIDEN AL, Drakeley S, Modi K, Mackie D, et al
Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey.
Vaccine. 2024;42:126437.
PubMed Abstract available - COCKERILL R, Horney JA, Penta SC, Silver A, et al
Factors associated with COVID-19 vaccination or intent to be vaccinated across three U.S. states.
Vaccine. 2024;42:126457.
PubMed Abstract available - TOP KA, Shulha HP, Muller MP, Valiquette L, et al
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study.
Vaccine. 2024;42:126445.
PubMed Abstract available - HSIEH HC, Chen CC, Liu WC, Wu SC, et al
Intranasal booster with SARS-CoV-2 RBD protein fused to E. coli enterotoxin a subunit after primary mRNA vaccination in mice.
Vaccine. 2024;42:126448.
PubMed Abstract available - SEDAGHAT M, Karami B, Najafi F, Shadmani FK, et al
Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers.
Vaccine. 2024;42:126424.
PubMed Abstract available - DOYON-PLOURDE P, Farley R, Krishnan R, Tunis M, et al
Direct quantitative comparison of benefits and risks of COVID-19 vaccines used in National Immunization Technical Advisory Groups Guidance during the first two years of the pandemic.
Vaccine. 2024;42:126406.
PubMed Abstract available - VYSE A, Wright H, Begier E
Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus.
Vaccine. 2024;42:126412.
PubMed Abstract available - PASCOE KM, Bishop S, Ci X, Ramirez M, et al
Factors that shape COVID-19 pediatric vaccine decision-making in rural agricultural communities: A qualitative study.
Vaccine. 2024;42:126389.
PubMed Abstract available - HOJO-SOUZA NS, de Castro JT, Rivelli GG, Azevedo PO, et al
SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern.
Vaccine. 2024;42:126394.
PubMed Abstract available - ALANSARI KDH, Buhl C, Thabit AK, Badr AF, et al
Validation of the Arabic translation of the vaccination attitudes examination (VAX) scale.
Vaccine. 2024;42:126411.
PubMed Abstract available - EARP M, Meng L, Black CL, Carter RJ, et al
Using regression tree analysis to examine demographic and geographic characteristics of COVID-19 vaccination trends over time, United States, May 2021-April 2022, National Immunization Survey Adult COVID Module.
Vaccine. 2024;42:126372.
PubMed Abstract available - PATRICK-SMITH M, Emary K, Hodgson SH, Thomas TM, et al
Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.
Vaccine. 2024;42:126391.
PubMed Abstract available - LYU X, Liu X, Hong H
Validation of the Chinese version of the vaccine conspiracy beliefs scale during COVID-19 pandemic and its correlates.
Vaccine. 2024;42:126395.
PubMed Abstract available - SOTOODEH A, Hedberg P, Granath F, Alfven T, et al
Sociodemographic determinants of COVID-19 vaccination in adolescents in Stockholm, Sweden.
Vaccine. 2024;42:126388.
PubMed Abstract available - ENGLAND A, Sung J, Deulofeu M, Soler LF, et al
Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax(R)) by HIPRA.
Vaccine. 2024;42:126386.
PubMed Abstract available - BERNADIN O, Cochin M, Driouich JS, Laprie C, et al
Preclinical evaluation in hamster model of the mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme.
Vaccine. 2024;42:126378.
PubMed Abstract available - AVERIN A, Sato R, Begier E, Gessner BD, et al
Annual public health and economic burden of medically attended respiratory syncytial virus illnesses among US adults.
Vaccine. 2024;42:126323.
PubMed Abstract available - LAEMMLE-RUFF I, Fryk JJ, Shenton P, Clothier HJ, et al
Detailed review of mortality reported following COVID-19 vaccination in Victoria, Australia: 2021-2023.
Vaccine. 2024;42:126368.
PubMed Abstract available - WEE LE, Malek MIBA, Tan J, Chiew C, et al
Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during omicron transmission.
Vaccine. 2024;42:126356.
PubMed Abstract available - FOTAKIS EA, Picasso E, Sacco C, Petrone D, et al
Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023-March 2024).
Vaccine. 2024;42:126375.
PubMed Abstract available - PRY JM, McCullough K, Lai KW, Lim E, et al
Defining long COVID using a population-based SARS-CoV-2 survey in California.
Vaccine. 2024;42:126358.
PubMed Abstract available - KRAUSE KD, D'Avanzo PA, Karr AG, Rhem C, et al
Vaccination uptake in LGBTQ adults in two US states: Findings from the QVax study.
Vaccine. 2024;42:126320.
PubMed Abstract available - SHIU EYC, Cheng SMS, Martin-Sanchez M, Au NYM, et al
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine.
Vaccine. 2024;42:126317.
PubMed Abstract available - VAN HEESBEEN R, Bastian AR, Omoruyi E, Rosen J, et al
Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study.
Vaccine. 2024;42:126273.
PubMed Abstract available - CHANG JY, Chang M, Huang S, Bosco J, et al
COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City.
Vaccine. 2024;42:126260.
PubMed Abstract available - CHUN J, Yoon D, Nowakowska A, Lee HD, et al
Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern.
Vaccine. 2024;42:126355.
PubMed Abstract available - CANETTI M, Barda N, Lustig Y, Weiss-Ottolenghi Y, et al
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers.
Vaccine. 2024;42:126308.
PubMed Abstract available - BLASCO A, Royuela A, Garcia-Gomez S, Gomez-Lozano N, et al
Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome.
Vaccine. 2024;42:126305.
PubMed Abstract available - KOMAMI M, Komu JG, Ishiguro Y, Sasaki M, et al
Detection of antibodies against H5 subtype highly pathogenic avian influenza viruses in multiple raccoons in Tokachi District, Hokkaido, Japan, from 2022 to 2023.
Virus Res. 2024 Dec 15:199515. doi: 10.1016/j.virusres.2024.199515.
PubMed Abstract available - MAO B, Le-Trilling VTK, Tang H, Hu J, et al
Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin.
Virus Res. 2024;350:199485.
PubMed Abstract available - GIRMA A
Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
Virus Res. 2024;350:199483.
PubMed Abstract available - KUROSE M, Yamamoto A, Elsayed AMA, Lawal-Ayinde BM, et al
Viral coexistence and insertional mutations in the ORF8 region of SARS-CoV-2: A possible mechanism of nucleotide insertion.
Virus Res. 2024;350:199478.
PubMed Abstract available - NO JS, Noh JY, Lee CY, Kim IH, et al
Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea.
Virus Res. 2024;350:199471.
PubMed Abstract available
Am J Med
Comments
Post a Comment